IE 11 is not supported. For an optimal experience visit our site on another browser.

Battle over COVID-19 booster shots ends with split decision


The Food and Drug Administration voted against approving a booster shoot of the Pfizer vaccine for Americans 16 and older, but the committee did vote in favor of 3rd doses for people 65 and older. If vaccine efficacy wanes over time, what happens from here? NBC’s Kathy Park has this week’s Sunday Focus.